Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Abrahm received her MD from the University of California at San Francisco in 1973, completed internship and residency at the Massachusetts General Hospital, and served as a chief resident at Moffitt Hospital (of UCSF). After completing a fellowship in hematology/oncology at the Hospital of the University of Pennsylvania, she joined the faculty in 1980 and worked there until December 2000. She joined DFCI in 2001 as director of the Pain and Palliative Care Program.
Dr. Janet Abrahm is a nationally recognized expert in Palliative Medicine (Abrahm 2014), and was instrumental in creating the clinical algorithms for symptom management for the research studies referred to below (Cooley et al 2013, 2014). She was a team member for both these unique decision-aid studies and a PCORI study that enable oncologists to relieve the most common sources of distress in lung cancer patients. She led effort that developed the clinical algorithms for management of pain, dyspnea, anxiety, depression, and fatigue that were then programmed, and the algorithms for patients with similar problems that are now undergoing review by patients and clinicians prior to programming. I continue to be the clinical collaboration and algorithm writer for our research team (funded in 2018-19 by an SBIR grant) that seeks to integrate primary symptom management aspects of palliative care into the EHR. Our team is also working with the VNS of NYC that serves all five boroughs, to standardize the symptom management offered by their organization using algorithms such as the ones we developed for the outpatient oncology group. The organization has nurse researchers and a large IT infrastructure into which we can insert the algorithms to test, once they are clinically vetted by the hospice staff.
Dana-Farber Cancer Institute450 Brookline AvenueShields-Warren 420Boston, MA 02215Get Directions